Ecofi Investissements SA Purchases New Position in IQVIA Holdings Inc. (NYSE:IQV)

Ecofi Investissements SA acquired a new position in shares of IQVIA Holdings Inc. (NYSE:IQV) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 51,400 shares of the medical research company’s stock, valued at approximately $10,581,000. IQVIA comprises approximately 5.8% of Ecofi Investissements SA’s investment portfolio, making the stock its 7th biggest holding.

A number of other hedge funds and other institutional investors have also made changes to their positions in IQV. 9258 Wealth Management LLC boosted its stake in IQVIA by 35.9% during the 4th quarter. 9258 Wealth Management LLC now owns 2,915 shares of the medical research company’s stock worth $674,000 after purchasing an additional 770 shares during the period. California State Teachers Retirement System boosted its stake in shares of IQVIA by 1.4% during the fourth quarter. California State Teachers Retirement System now owns 297,141 shares of the medical research company’s stock worth $68,752,000 after buying an additional 4,206 shares during the period. APG Asset Management US Inc. purchased a new position in shares of IQVIA during the fourth quarter worth about $15,627,000. KBC Group NV increased its position in IQVIA by 523.4% in the 4th quarter. KBC Group NV now owns 272,925 shares of the medical research company’s stock valued at $63,149,000 after acquiring an additional 229,147 shares during the period. Finally, NEOS Investment Management LLC lifted its position in IQVIA by 70.8% during the 4th quarter. NEOS Investment Management LLC now owns 2,590 shares of the medical research company’s stock worth $599,000 after acquiring an additional 1,074 shares during the period. Institutional investors and hedge funds own 89.62% of the company’s stock.

Insider Activity

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the business’s stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the sale, the insider now directly owns 19,536 shares in the company, valued at $4,812,302.88. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. JPMorgan Chase & Co. upped their price objective on shares of IQVIA from $260.00 to $288.00 and gave the stock an “overweight” rating in a research report on Monday, August 5th. The Goldman Sachs Group started coverage on shares of IQVIA in a research report on Thursday, June 6th. They issued a “buy” rating and a $270.00 price objective for the company. StockNews.com downgraded IQVIA from a “buy” rating to a “hold” rating in a research note on Friday. Royal Bank of Canada assumed coverage on IQVIA in a research note on Wednesday, September 4th. They issued an “outperform” rating and a $275.00 price target on the stock. Finally, Barclays increased their price objective on IQVIA from $255.00 to $275.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 23rd. Five equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, IQVIA has a consensus rating of “Moderate Buy” and an average price target of $267.00.

IQVIA Stock Down 0.6 %

IQV stock opened at $234.79 on Monday. The company has a 50 day moving average price of $241.49 and a two-hundred day moving average price of $233.19. The company has a debt-to-equity ratio of 1.80, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $42.80 billion, a P/E ratio of 32.08, a PEG ratio of 2.25 and a beta of 1.49. IQVIA Holdings Inc. has a one year low of $167.42 and a one year high of $261.73.

IQVIA (NYSE:IQV) last posted its quarterly earnings results on Monday, July 22nd. The medical research company reported $2.64 EPS for the quarter, beating the consensus estimate of $2.57 by $0.07. IQVIA had a return on equity of 28.59% and a net margin of 9.39%. The company had revenue of $3.81 billion during the quarter, compared to analysts’ expectations of $3.79 billion. During the same quarter in the previous year, the business earned $2.22 EPS. The firm’s revenue was up 2.3% on a year-over-year basis. As a group, sell-side analysts expect that IQVIA Holdings Inc. will post 10.25 EPS for the current year.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.